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Background: 5-Fluorouracil (5-FU) induces intestinal mucositis, which is characterized by epithelial
ulcerations in the mucosa and clinical manifestations, such as pain and dyspeptic symptoms. Cytokines
participate in the inﬂammatory and functional events of intestinal mucositis. IL-4 is an important medi-
ator of intestinal inﬂammation, with either anti-inﬂammatory or pro-inﬂammatory functions, depending
on the model of intestinal inﬂammation. This study aimed to evaluate the role of IL-4 in 5-FU-induced
intestinal mucositis.
Methods: IL-4+/+ or IL-4/ mice (25–30 g) were intraperitoneally injected with 5-FU (450 mg/Kg) or sal-
ine (C). After 3 days, the mice were sacriﬁced and the duodenum was evaluated for epithelial damage,
MPO activity and cytokine concentration.
Results: 5-FU induced signiﬁcant damage in the intestinal epithelium of IL-4+/+ mice (reduction in the vil-
lus/crypt ratio: control = 3.31 ± 0.21 lm, 5-FU = 0.99 ± 0.10 lm). However, the same treatment did not
induce signiﬁcant damage in IL-4/ mice (5-FU = 2.87 ± 0.19 lm) compared to wild-type mice. 5-FU-
induced epithelial damage increased the MPO activity (neutrophil number) and the level of pro-
inﬂammatory cytokines (IL-4, TNF-a, IL-1b and CXCL-8) in the duodenum. These results were not
observed in IL-4/ mice treated with 5-FU.
Conclusion: Our data suggest that IL-4 participates as a pro-inﬂammatory cytokine in a 5-FU-induced
intestinal damage model and suggests that IL-4 antagonists may be novel therapeutics for this condition.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Intestinal inﬂammation causes signiﬁcant alterations in the
structure of the mucous membrane, such as polymorphonuclear
inﬁltration with subsequent damage to the epithelial barrier [1].
Cytokines can induce apoptosis, further contributing to barrier
dysfunction during intestinal inﬂammation [2].
An important problem in oncology clinics is the cytotoxic effect
of cancer chemotherapy on the gastrointestinal tract. For example,
mucositis is a major oncological problem caused by the cytotoxic-
ity of chemotherapy. The antimetabolite agent 5-ﬂuorouracil
(5-FU) has been used in the treatment of a range of cancers and
can induce intestinal damage, referred to as intestinal mucositis
[3]. Soares et al. [4] demonstrated that in animal models, intestinal
mucositis induced by 5-FU is associated with neutrophil inﬁltra-
tion, increased pro-inﬂammatory cytokine levels and, importantly,
delayed gastric emptying.de Morfologia, Faculdade de
onel Nunes de Melo, 1315,
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sevier OA license.IL-4 is a critical mediator of intestinal inﬂammation. It regulates
gastrointestinal smooth muscle during inﬂammatory processes [5]
and functions as either an anti-inﬂammatory or pro-inﬂammatory
molecule depending on the model of intestinal inﬂammation [6].
Additionally, the pro-inﬂammatory effect of IL-4 in intestinal
inﬂammation may be caused by increased production of IFN-c
[7]. Several studies indicate that IL-4 is an important cytokine in
allergic intestinal disease and the development of pathological
Th2 responses [8]. Thus, the aims of this study were to evaluate
the role of IL-4 in intestinal mucositis induced by 5-FU and to exam-
ine the underlying mechanisms of 5-FU-induced mucositis.2. Materials and methods
2.1. Mice
Wild-type (WT) and IL-4/ (Il4tm1Nnt/J) C57BL/6 mice from the
samegeneticbackground(6–8 weeksold,n = 8animals/group)were
kept in a temperature-controlled room with water supplied ad libi-
tum. All protocols were approved by the local ethics committee.
P.M.G. Soares et al. / Cytokine 61 (2013) 46–49 472.2. Mouse model of intestinal mucositis induced by 5-FU
Mice were intraperitoneally injected with a single dose of 5-FU
(450 mg/kg) (ICN Pharmaceuticals) or saline as a control (vehicle)
and sacriﬁced after 3 days. Samples of the duodenum were re-
moved for histological analysis and stored at 70 C in a solution
containing protease inhibitors, which were required for the future
evaluation of cytokine levels (IL-4, TNF-a, IL-1b and CXCL-8) and
MPO activity.2.3. Determination of leukocyte number
Mice were anesthetized, and blood samples were collected. The
total number of white cells was determined after dilution in Turk’s
solution using a Neubauer chamber. The results are expressed as
the number of leukocytes per mL of sample.Fig. 1. Histopathological analysis. IL-4+/+ (n = 8) and IL-4/ mice (n = 8) were pre-treat
taken for measurement of villus height (panel A), crypt depth (panel B) and villus/crypt r
type mice + 5-FU (panel E and H), showing: shortened villi recovered with fattened and
(arrowhead), loss of normal crypt architecture (panel E and H). IL-4/ mice + 5-FU (pane
100X and G, H, I; 400X). The values were reported as mean ± S.E.M. ⁄p < 0.05 compar
Bonferroni’s post-hoc test.2.4. Intestinal morphometry and histopathology
Segments of duodenum were ﬁxed and stained with hematoxy-
lin and eosin. Measurements of villus heights and crypt depths
were performed via microscopy. 10 intact and well-oriented villi
and crypts were measured and averaged for each sample. The
microscopy analysis was double-blinded.2.5. Intestinal MPO activity
Myeloperoxidase activity in the duodenum (a quantitative mea-
surement of neutrophil inﬁltration) was assayed as previously de-
scribed [9]. The results were calculated by comparing the optical
density of the duodenum tissue with a standard curve of neutro-
phil (>95% purity) numbers.ed with saline (C) or 5-FU (450 mg/kg). After 3 days, segments of duodenum were
atio (panel C). Control mice showing normal villi and crypts (panel D and G). Wild-
vacuolated cells (arrow), and inﬂammatory cell inﬁltration in the lamina propria
l F and I), showing preservation of the villi and crypts. H&E staining (panels D, E, F;
ed to control (C), # p < 0.05 compared to 5-FU + IL-4+/+. Analysis of variance and
48 P.M.G. Soares et al. / Cytokine 61 (2013) 46–492.6. Detection of cytokines (IL-4, TNF-a, IL-1b and CXCL-8) in the
duodenum
Cytokine concentrations in the duodenum (IL-4, TNF-a, IL-1b
and CXCL-8) were determined by enzyme-linked immunosorbent
assay (ELISA) using protocols supplied by the manufacturer (R&D
Systems, Minneapolis, USA). The results are expressed as pico-
grams/mL.
2.7. Statistical analysis
The results are reported as means ± standard error of the mean
(S.E.M.) for each group. ANOVA was performed followed by Bonfer-
roni’s test. Values were considered signiﬁcant at p < 0.05.3. Results
The 5-FU-treated IL-4/ mice exhibited leukopenia (1585.00 ±
247.30 cells/mL), similar to wild-type mice (2513.00 ± 166.30
cells/mL) with the same treatment. 5-FU-treated wild-type mice
were signiﬁcantly different from untreatedwild-typemice in terms
of leukocyte number (7173.00 ± 1032.50 cells/mL) (p < 0.05). How-
ever, IL-4/ mice displayed attenuated 5-FU-induced intestinal
mucositis. As shown in Fig. 1, 5-FU treatment caused a signiﬁcant
shortening of villi (panel A), an increase in crypt depth (panel B),
and a decrease in the villus height/crypt depth ratio (panel C) in
wild-type mice.
Fig. 1 presents duodenum photomicrographs that demonstrate
the 5-FU-induced intestinal mucositis in wild-type animals. This
conditionwas characterizedby the loss of normal crypt architecture,
shortened villi with fattened, vacuolated cells and inﬂammatory cell
inﬁltration into the lamina propria (panel E). 5-FU-treated IL-4–/–A B
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Fig. 2. Neutrophil inﬁltration and concentration of TNF- a, IL-1b, CXCL-8. MPO activity a
MPO activity of IL-4+/+ and IL-4/ mice pre-treated with saline (C) or 5-FU. Panel B, C
IL-4/ mice 5-FU pre-treated or saline (C). The values were reported as mean ± S.E.M.
variance and Bonferroni’s post-hoc test. We used n = 8 for all groups.mice (panel F) demonstrated preservation of the villi and crypts
when compared to 5-FU-treated wild-type mice (panel D).
An increase in IL-4 concentration (101.67 ± 11.10 pg/mL) was
observed in 5-FU-treated wild-type mice compared to untreated
wild-type mice (43.68 ± 14.70 pg/mL). In addition, as shown in
Fig. 2, neutrophil inﬁltration in the duodenum in 5-FU-treated
IL-4+/+ mice was 2-fold greater than that in treated IL-4/ mice.
5-FU treatment resulted in increased TNF-a, IL-1b and CXCL-8 con-
centrations in the duodenum (1.6-, 3.2- and 1.6-fold higher the
concentrations than those in the control group, respectively). In
contrast, 5-FU treatment did not increase cytokine expression in
mice lacking IL-4.4. Discussion
In the present study, we observed that 5-FU induced intestinal
mucositis with a concomitant increase in IL-4 concentration in
wild-type mice compared to untreated wild-type mice. Further-
more, knockout of IL-4 efﬁciently prevented the pathological alter-
ations of 5-FU-induced mucositis (a decrease in the villus/crypt
ratio, neutrophil inﬁltration and an increase in the level of the
cytokines TNF-a, IL-b and CXCL-8) in the duodenum of the mice.
Despite reports of both anti- and pro-inﬂammatory effects for
IL-4 depending on the animal model, we demonstrated that this
cytokine is pro-inﬂammatory in an intestinal mucositis model.
Cytokines, such as TNF-a, IL-b and CXCL-8, are critical media-
tors of intestinal inﬂammation. Williams [10] reported that the
inﬂammatory cytokines TNF-a and IL-b contribute to the severity
and maintenance of injury in intestinal mucositis. CXCL-8 is an-
other important chemokine in the intestinal inﬂammatory process,
as it is recognized as a powerful neutrophil chemotactic factor [11].
Interestingly, IL-4 has either anti- or pro-inﬂammatory effects inC 5-FU C 5-FU
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nd cytokines concentration were evaluated by colorimetric method. Panel A shows
and D, respectively, show concentration of TNF- a, IL-1b and CXCL-8 of IL-4+/+ and
⁄p < 0.05 compared to saline (C), # p < 0.05 compared to 5-FU + IL-4+/+. Analysis of
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transfection in mice promotes colitis, which is mast cell and T-cell
independent but monocyte and granulocyte dependent [6]. In the
same study, TNF-a was also found to be an important mediator
of colitis. In oxazolone-induced colitis, a similar pro-inﬂammatory
effect of IL-4 was observed [12]. The production of cytokines, such
as IFN-c, may mediate the pro-inﬂammatory effect of IL-4 in the
intestinal inﬂammation model [7].
We observed that IL-4/ mice experienced less severe intesti-
nal injury compared to wild-type mice when treated with 5-FU.
In addition, these deﬁcient mice demonstrated reduced neutrophil
inﬁltration and a decrease in TNF-a, IL-1b and CXCL-8 in the
duodenum. These data suggest that IL-4 may play an important
pro-inﬂammatory role in 5-FU-induced intestinal mucositis. The
observation that IL-4/ mice experience a lesser reduction in the
villus height/crypt depth ratio in the duodenum and an improve-
ment in the morphology of the analyzed intestinal segments sup-
ports our hypothesis that reducing these inﬂammatory
parameters by removing IL-4 improves the outcome of 5-FU-in-
duced mucositis.
It has been demonstrated that IL-4 promotes the migration of
leukocytes, including neutrophils, via increased CCL2 expression
or by an increase in the expression of inﬂammatory proteins, such
as sTNFR1 [13]. However, the mechanisms listed above were not
evaluated in our study. Moreover, it was reported that IL-4 is
responsible for increased IL-8 expression and delays in neutrophil
apoptosis, contributing to an increase in the population of these
cells [14]. When inﬂammation is induced in the intestinal mucosa,
IL-4/mice show less damage, diminished neutrophil activity and
a lesser increase in TNF-a mRNA compared to wild-type mice [8].
In conclusion, our study establishes a role for IL-4 in 5-FU-
induced intestinal mucositis. This study suggests that treatment
with IL-4 antagonists may be a logical novel therapeutic strategy
for this condition.
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